BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Data From Borealis-1 Trial Showing Clinical Benefit With Apatorsen In Metastatic Bladder Cancer

  June 1, 2015

   · 

  8 min read
• Pharm Country

  Bayer HealthCare Pharmaceuticals Release: Survey Shows Most Men With Advanced Prostate Cancer Ignore Their Symptoms As Disease Progresses[1]

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Targovax Releases TGO1 RAS-Mutation-Specific Immunotherapy Data At ASCO

  June 1, 2015

   · 

  2 min read
• Biotech Beach

  Biocept, Inc. Granted U.S. Patent For Blood Collection And Transport Tube

  June 1, 2015

   · 

  1 min read
• Drug Development

  ASCO15: Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data Presentations In The AETHERA Post-Transplant Consolidation Setting And In Frontline DLBCL At ASCO Annual Meeting

  June 1, 2015

   · 

  13 min read
• Drug Development

  ASCO15: Boehringer Ingelheim Release: Superior Overall Survival For Afatinib Compared To Erlotinib Demonstrated In Head-To-Head Trial In Patients With Previously Treated Advanced Squamous Cell Carcinoma Of The Lung

  June 1, 2015

   · 

  12 min read
• Pharm Country

  Pershing Square Foundation Establishes $10 Million Endowment To Support CSHL Life Science Research

  June 1, 2015

   · 

  3 min read
• Biotech Bay

  ASCO15: Oncotype DX Presentations At ASCO In Breast And Prostate Cancer Reinforce Genomic Health, Inc.'s Leadership In Optimizing Cancer Treatment

  June 1, 2015

   · 

  7 min read
• Drug Development

  Genentech’s Perjeta Regimen Helped People With HER2-Positive Early Breast Cancer Live Longer Without Their Disease Returning Or Getting Worse Compared To Herceptin And Chemotherapy

  June 1, 2015

   · 

  10 min read
• Drug Development

  Bristol-Myers Squibb Release: Phase III Checkmate -067 Trial Demonstrates Superior Progression-Free Survival Of Opdivo+Yervoy Regimen Or Opdivo Monotherapy Vs. Yervoymonotherapy In Previously Untreated Patients With Advanced Melanoma

  June 1, 2015

   · 

  1 min read